Technical Analysis for PULM - Pulmatrix, Inc.

Grade Last Price % Change Price Change
F 1.63 -2.98% -0.05
PULM closed down 2.98 percent on Monday, March 18, 2024, on 58 percent of normal volume.
Earnings due: Mar 28
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Lower Bollinger Band Walk Weakness -2.98%
New 52 Week Low Weakness -2.98%
Outside Day Range Expansion -2.98%
Gapped Up Strength -2.98%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 9 hours ago
60 Minute Opening Range Breakdown about 12 hours ago
Down 5% about 12 hours ago
Down 3% about 12 hours ago
Fell Below Lower Bollinger Band about 12 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its iSPERSE technology. The company's proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease and other treatments. Pulmatrix, Inc. is based in Lexington, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Clinical Development Rare Diseases Chronic Obstructive Pulmonary Disease Cystic Fibrosis Pulmonary Disease Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pulmonology Treatment Of Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Pulmonary Rehabilitation

Is PULM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.185
52 Week Low 1.57
Average Volume 15,602
200-Day Moving Average 2.16
50-Day Moving Average 1.85
20-Day Moving Average 1.86
10-Day Moving Average 1.81
Average True Range 0.14
RSI (14) 34.21
ADX 20.02
+DI 13.55
-DI 24.01
Chandelier Exit (Long, 3 ATRs) 1.62
Chandelier Exit (Short, 3 ATRs) 2.00
Upper Bollinger Bands 2.09
Lower Bollinger Band 1.64
Percent B (%b) -0.01
BandWidth 24.17
MACD Line -0.04
MACD Signal Line -0.01
MACD Histogram -0.0323
Fundamentals Value
Market Cap 5.95 Million
Num Shares 3.65 Million
EPS -4.44
Price-to-Earnings (P/E) Ratio -0.37
Price-to-Sales 0.94
Price-to-Book 0.32
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.84
Resistance 3 (R3) 1.85 1.79 1.81
Resistance 2 (R2) 1.79 1.74 1.79 1.79
Resistance 1 (R1) 1.71 1.70 1.68 1.70 1.78
Pivot Point 1.65 1.65 1.64 1.65 1.65
Support 1 (S1) 1.57 1.60 1.54 1.56 1.48
Support 2 (S2) 1.51 1.56 1.51 1.47
Support 3 (S3) 1.43 1.51 1.46
Support 4 (S4) 1.42